Can an acute bacterial infection (e.g., cellulitis, urinary tract infection, or respiratory infection) exacerbate the pain, burning, tingling, or autonomic symptoms in an adult patient with known small‑fiber neuropathy?

Can Infection Intensify Symptoms of Preexisting Small Fiber Neuropathy?

Yes, acute bacterial infections can exacerbate symptoms in patients with established small fiber neuropathy, triggering or worsening burning pain, dysesthesias, and autonomic dysfunction through immune-mediated mechanisms.

Evidence for Infection-Related Exacerbations

The clearest evidence comes from pediatric cases where acute post-infectious immune-mediated small fiber neuropathy developed following bacterial infections 1. In this series, 3 of 5 children had preceding or concomitant infections (including urinary tract infections), presenting with severe paroxysmal burning pain in hands and feet. The monophasic tempo and response to immunotherapy strongly suggested acute immune-mediated causality similar to Guillain-Barré syndrome 1.

Additionally, acute small fiber sensory neuropathy has been documented as a post-infectious variant, with 4 of 6 patients reporting antecedent illness (diarrhea in 3, urinary tract infection in 1) 2. These patients developed acute onset numbness and burning dysesthesia within 4 weeks of infection, with CSF showing albuminocytological dissociation—a hallmark of immune-mediated nerve injury 2.

Mechanism of Symptom Exacerbation

The pathophysiology involves:

• Immune activation: Infections trigger systemic inflammatory responses that can amplify existing nerve fiber dysfunction
• Cytokine-mediated sensitization: Pro-inflammatory mediators lower pain thresholds in already-damaged small fibers
• Autonomic dysregulation: Infection-related stress compounds baseline autonomic dysfunction in SFN patients

Since small fiber neuropathy involves dysfunction of thinly myelinated Aδ and unmyelinated C fibers 3, and these fibers are already compromised, any systemic inflammatory state from bacterial infection can worsen their function.

Clinical Recognition

Watch for these patterns in your SFN patients with acute infection:

• Intensification of baseline burning, tingling, or stabbing pain beyond what the infection site alone would explain
• Spread of symptoms from typical distal distribution to more proximal areas
• New or worsened autonomic symptoms: orthostatic dizziness, gastrointestinal dysmotility, palpitations, or thermoregulatory dysfunction 4, 3
• Temporal relationship: symptom escalation coinciding with infection onset

Management Approach

Treat the underlying infection aggressively while simultaneously managing neuropathic symptom flares:

1. Antimicrobial therapy: Appropriate antibiotics for the specific bacterial infection
2. Neuropathic pain escalation:
   • First-line: Increase gabapentin or pregabalin dosing temporarily 4
   • Consider adding mexiletine if burning pain is severe 1
   • Topical lidocaine patches for localized exacerbations 4
3. Monitor for post-infectious immune phenomena: If symptoms persist beyond infection resolution, consider short-course corticosteroids or IVIG, particularly if CSF shows albuminocytological dissociation 1, 2

Critical Caveat

Do not attribute all symptom worsening to the known SFN—ensure you're not missing a new neurological complication of the infection itself (meningitis, epidural abscess, etc.). The key distinguishing feature is that infection-related SFN exacerbations maintain the patient's baseline distribution pattern (length-dependent vs. non-length-dependent) but with increased intensity 5.

Most patients experience symptom improvement within weeks to months after infection clearance 1, 2, though the underlying SFN remains chronic and requires ongoing management 4, 5.